Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 226 entries
View as:

Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06439888 Org: User:
Start: 07/11/24 End: 01/31/27 Due: 01/31/28

Study Comparing Efficacy of Doxorubicin With Trabectedin Followed by Trabectedin Versus Doxorubicine in Patients With Leiomyosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT02997358 Org: User:
Start: 01/18/17 End: 07/28/21 Due: 07/28/22

Pediatric Hepatic Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04274868 Org: User:
Start: 09/10/15 End: 09/30/25 Due: 09/30/26

Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary

Phase: N/A Priority: Normal
NCT ID: NCT00126269 Org: User:
Start: 05/31/03 End: - Due: -

Analgesia of Fibula Free Flap Donor Site by Peri-Neuronal Catheter in Oro-Pharyngeal Carcinoma Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00181038 Org: User:
Start: 06/30/04 End: - Due: -

Standard Neoadjuvant Chemotherapy Versus Genomic Driven Chemotherapy in Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01180335 Org: User:
Start: 01/31/09 End: 12/31/11 Due: 12/31/12

Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00811759 Org: User:
Start: 06/30/07 End: - Due: -

LIFSCREEN : Evaluation of Whole Body MRI for Early Detection of Cancers in Subjects With P53 Mutation (Li-Fraumeni Syndrome)

Phase: N/A Priority: Normal
NCT ID: NCT01464086 Org: User:
Start: 10/27/11 End: 10/09/17 Due: 10/09/18

Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT05830084 Org: User:
Start: 06/16/23 End: 06/30/26 Due: 06/30/27

Diagnostic Qualities of the Positron Emission Tomography Coupled to the Scanner (PET / CT) in the Assessment of Response to Non-Hodgkin's Lymphoma Therapy in Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT02488369 Org: User:
Start: 03/31/11 End: 01/25/18 Due: 01/25/19

Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract

Phase: N/A Priority: Normal
NCT ID: NCT00127595 Org: User:
Start: 01/31/02 End: 04/30/05 Due: 04/30/06

Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways

Phase: N/A Priority: Normal
NCT ID: NCT04349293 Org: User:
Start: 09/08/16 End: 09/30/21 Due: 09/30/22

Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal Chemohyperthermia

Phase: N/A Priority: Normal
NCT ID: NCT00180960 Org: User:
Start: 06/30/03 End: - Due: -

A Phase Ib Study of the Safety, Tolerability and Efficacy of LY2780301 in Combination With Gemcitabine

Phase: N/A Priority: Normal
NCT ID: NCT02018874 Org: User:
Start: 09/30/13 End: 04/30/16 Due: 04/30/17

A Phase II Study of Velcade® in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00346645 Org: User:
Start: 06/30/06 End: 12/31/07 Due: 12/31/08

Hepatic Intra-Arterial Administration of Ipilimumab in Combination With Intra-venous Nivolumab for Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04823403 Org: User:
Start: 11/13/20 End: 11/30/24 Due: 11/30/25

Study Comparing Isolated Pelvic Perfusion With TNF-α 0.3 mg and Melphalan 1.5 mg/kg Versus Standard Treatment in Patients With Non Resectable, Recurrent Gynaecologic or Digestive Pelvic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00949039 Org: User:
Start: 02/28/09 End: 03/31/14 Due: 03/31/15

Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT01516567 Org: User:
Start: 04/01/12 End: 12/31/21 Due: 12/31/22

Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma (ALCL 99)

Phase: N/A Priority: Normal
NCT ID: NCT00006455 Org: User:
Start: 11/26/99 End: 09/03/20 Due: 09/03/21

A Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03212469 Org: User:
Start: 06/20/17 End: 02/24/25 Due: 02/24/26

Adjuvant Immunotherapy After Salvage Surgery in Head and Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03406247 Org: User:
Start: 02/12/18 End: 11/30/27 Due: 11/30/28

Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00126256 Org: User:
Start: 02/28/02 End: 02/28/06 Due: 02/28/07

Axillary Reverse Mapping Using Near-infrared Imaging in Invasive Breast Cancer: Predictors of Nodal Positivity

Phase: N/A Priority: Normal
NCT ID: NCT02994225 Org: User:
Start: 03/10/17 End: 08/05/19 Due: 08/05/20

Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL

Phase: N/A Priority: Normal
NCT ID: NCT00180895 Org: User:
Start: 06/30/04 End: - Due: -

Unmodified Versus Leuko-Reduced Allogeneic Red Blood Cells Transfusion in Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00180869 Org: User:
Start: 09/30/97 End: - Due: -